Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ADVANCE: Cinacalcet Plus Low-Dose Vitamin D and Vascular Calcification in Hemodialysis
2006-002662-19Phase 4Completed
- Sponsor
- Amgen
- Start
- Sep 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of cinacalcet in secondary hyperparathyroidism (SHPT) and chronic kidney disease (CKD) (2 arms), sponsored by Amgen. Primary endpoint: Percent change from baseline in coronary artery calcification (CAC) score at week 52. Started Sep 2006; status: completed.
02
Drugs
cinacalcet
03
Conditions
secondary hyperparathyroidism (SHPT)chronic kidney disease (CKD)
Beyond the preview
Go deeper on 2006-002662-19.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-002662-19.